| 新兽药名称 | 研制单位 | 类别 | 新兽药注册证号 | | --- | --- | --- | --- | | 猫鼻气管炎、杯状病毒病、 | 瑞普生物股份有限公司、天津 | | | | 泛白细胞减少症三联灭活 | | | | | | 瑞普生物技术股份有限公司空 | | （2025）新兽药证字 | | 疫 苗 （ 株 RPVF0304 | | 三类 | | | | 港经济区分公司、瑞普（保定） | | 127 号 | | +RPVF0207 株 +RPVF0110 | | | | | | 生物药业有限公司 | | | | 株） | | | | 证券代码：300119 证券简称：瑞普生物 公告编号：2025-091 瑞普生物股份有限公司 关于取得新兽药注册证书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 瑞普生物股份有限公司（以下简称"公司""瑞普生物"）自主研制的猫鼻 气管炎、杯状病毒病、泛白细胞减少症三联灭活疫苗（RPVF0304 株+RPVF0207 株+RPVF0110 株）于 2023 年 8 月 22 日通过农业农村部组织的应急评价， ...

Group 1 - The SW Agricultural, Forestry, Animal Husbandry, and Fishery industry outperformed the CSI 300 index, with an overall increase of 16.36% from January to November 2025, surpassing the index by approximately 3.18 percentage points [12][13][14] - All sub-sectors within the industry recorded positive returns, with significant increases in animal health (36.27%), fishery (35.22%), agricultural product processing (21.88%), feed (12.48%), breeding (11.53%), and planting (8.49%) [13] - Approximately 83% of stocks in the industry achieved positive returns, with around 5% of stocks increasing by over 100%, and 17% recording negative returns [14][17] Group 2 - The breeding industry is experiencing a gradual reduction in the number of breeding sows, with a current stock of 40.35 million heads, which is 1.1% lower than the previous year [23][24] - The price of live pigs has shown a downward trend in 2025, with an average price of 11.65 yuan/kg as of November 24, down 26% from the beginning of the year, but is expected to gradually recover in 2026 [26] - The profitability of pig farming has turned negative, with self-breeding losses at 135.9 yuan per head and external piglet purchases at 234.63 yuan per head, but a recovery is anticipated in 2026 [31] Group 3 - The meat chicken breeding sector faced challenges in profitability during 2025, with the average price of broiler chicks fluctuating and a significant decline in profitability [33][35] - The supply of yellow feathered chickens is expected to remain relatively abundant in 2026, with a high stock of breeding chickens [45][47] - The overall feed production in China is projected to continue its recovery, with a total production of 15.85 million tons in the first half of 2025, reflecting a year-on-year increase of 7.7% [50] Group 4 - The prices of feed raw materials such as corn and soybean meal have shown fluctuations, with corn prices recovering from a low of 2115.59 yuan/ton to around 2300.88 yuan/ton by late November 2025 [52][53] - The global supply of corn is expected to remain ample, with a projected production of 128.6 million tons for the 2025/26 season, indicating limited price recovery potential [55] - The overall market for pet food in China is anticipated to grow, with an increase in exports and a rising domestic market [38][40]

格隆汇11月25日丨瑞普生物(300119.SZ)在互动平台表示，公司及国内目前均无H5N5禽流感专用疫苗， 国外流行的H5N5毒株属clade2.3.4.4b基因分支，疫苗保护效果评估核心看基因分支而非血清型，公司现 有的H5+H7疫苗含该分支毒株成份，理论上可提供较好保护。 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002868 | *ST绿康 | 39.79 | -4.99% | 4766.0 | ly 1896.39万 | | 600201 | 生物股份 | 11.55 | -1.79% | 35.65万 | 4.10亿 | | 920275 | 驱动力 | 9.37 | -1.78% | 1.71万 | 1609.07万 | | 603566 | 普来柯 | 13.35 | -0.22% | - 3.49万 | 4679.01万 | | 688526 | 科前生物 | 15.37 | -0.13% | 2.79万 | 4303.02万 | | 603718 | 海利生物 | 6.70 | 0.60% | 5.32万 | 3561.82万 | | 300119 | 瑞普生物 | 19.56 | 0.77% | 3.39万 | 6606.24万 | | 002688 | 金河生物 | 6.01 | 0.84% | 9.42万 | 5642.15万 | | 9 ...

Core Insights - The Chinese pet industry has experienced unprecedented growth since the 21st century, transitioning from viewing pets as mere tools for guarding to recognizing them as essential emotional companions and family members [1][9] - The pet service sector has diversified significantly, encompassing medical, grooming, boarding, and training services to meet the evolving needs of pet owners [1][9] - The market for pet services in China is projected to grow from 34.034 billion yuan in 2015 to 104.47 billion yuan in 2024, with a compound annual growth rate (CAGR) of 13% [1][10] Pet Service Industry Overview - The pet industry includes all activities related to pets, such as breeding, trading, and providing goods and services like pet food, supplies, and services [3] - Pet services are defined as non-physical consumption services for pets and their owners, covering a wide range of offerings from grooming and medical care to training and insurance [3] Market Growth and Trends - The number of urban pets in China is expected to rise from 87.46 million in 2017 to 124.11 million by 2024, with a CAGR of 5.13% [5] - The pet consumption market in China is anticipated to expand from 97.8 billion yuan in 2015 to 300.2 billion yuan in 2024, with a CAGR of 13.27% [8] - In 2024, pet food is projected to account for 52.8% of the market, while pet services will represent 34.8% [8] Industry Development History - The establishment of the China Small Animal Protection Association in 1992 marked the beginning of the pet industry in China, promoting the concept of pets as companions [5] - Over the past thirty years, the pet service industry has evolved from basic breeding and trading to a comprehensive service model covering the entire lifecycle of pets [5][6] Industry Structure and Key Players - The pet service industry features a diverse competitive landscape, with key players in medical services including New Ruipeng and Ruipai, while grooming and boarding services are dominated by regional brands like Baozaiwu and Paiduo [10] - The market remains fragmented, with opportunities for growth through service extension, technological empowerment, and brand building [10] Future Trends in Pet Services - The industry is expected to embrace intelligent technology, integrating smart wearables and online platforms for enhanced pet health management and service efficiency [12] - Services will increasingly focus on emotional value and personalized experiences, such as customized training and memorial services for pets [13] - The service model will diversify, combining online and offline experiences, with O2O platforms and community-based services enhancing user engagement [14]

Core Viewpoint - The animal health sector experienced a slight decline of 0.31% on November 19, with Xianfeng Holdings leading the losses, while the Shanghai Composite Index rose by 0.18% to close at 3946.74 [1]. Group 1: Market Performance - The animal health sector's individual stock performance varied, with notable gainers including Qudongli (up 3.98% to 10.71) and ST Lvkang (up 3.80% to 46.40) [1]. - Conversely, several stocks faced declines, such as Jinhai Biological (down 0.96% to 6.19) and Shunlian Biological (down 1.08% to 10.12) [1][2]. Group 2: Trading Volume and Capital Flow - The total trading volume for the animal health sector was significant, with Qudongli achieving a volume of 34,000 hands and a transaction value of approximately 35.9 million yuan [1]. - The sector saw a net outflow of 49.13 million yuan from institutional investors, while retail investors contributed a net inflow of 548.09 million yuan [2]. Group 3: Individual Stock Capital Flow - Among individual stocks, Shengong Holdings experienced a net outflow of 31.56 million yuan from retail investors, while Biotech Holdings saw a net inflow of 555.72 million yuan from retail investors [3]. - The stock with the highest net inflow from retail investors was Biotech Holdings, with 555.72 million yuan, while the largest net outflow was from Yongshun Biological, totaling 408.61 million yuan [3].

Core Insights - The animal health sector experienced a decline of 0.24% on November 17, with Dayu Biological leading the drop [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Stock Performance - Notable gainers included: - Qudongli (code: 920275) with a closing price of 10.68, up 5.12% [1] - *ST Lvkang (code: 002868) with a closing price of 42.57, up 5.01% [1] - Houfeng Holdings (code: 002141) with a closing price of 3.91, up 2.62% [1] - Major decliners included: - Dayu Biological (code: 920970) with a closing price of 8.70, down 3.87% [2] - Ruipu Biological (code: 300119) with a closing price of 20.61, down 2.92% [2] - Zhongmu Co., Ltd. (code: 600195) with a closing price of 7.94, down 1.98% [2] Capital Flow - The animal health sector saw a net outflow of 10.15 million yuan from institutional investors, while retail investors experienced a net outflow of 20.76 million yuan [2] - Conversely, speculative funds recorded a net inflow of 30.91 million yuan [2] Individual Stock Capital Flow - Notable capital flows included: - Biological Shares (code: 600201) with a net inflow of 12.08 million yuan from institutional investors [3] - Xianfeng Holdings (code: 002141) with a net inflow of 9.50 million yuan from institutional investors [3] - Ruipu Biological (code: 300119) with a net inflow of 1.05 million yuan from speculative funds [3] - Decliners in capital flow included: - *ST Lvkang (code: 002868) with a net outflow of 0.79 million yuan from institutional investors [3] - Hai Li Biological (code: 603718) with a net outflow of 2.82 million yuan from institutional investors [3]

Investment Rating - The report maintains an "Overweight" rating for the agriculture, forestry, animal husbandry, and fishery industry [48]. Core Viewpoints - The SW agriculture, forestry, animal husbandry, and fishery industry outperformed the CSI 300 index, rising by 4.87% from October 31, 2025, to November 13, 2025, exceeding the index by approximately 5.04 percentage points [11]. - All sub-sectors within the industry recorded positive returns during the same period, with notable increases in agricultural product processing (9.03%), fishery (8.12%), animal health (5.57%), planting (4.57%), breeding (2.94%), and feed (2.45%) [12]. - Over 90% of individual stocks in the industry achieved positive returns, indicating strong overall market performance [13]. - The industry valuation has rebounded, with the overall price-to-book (PB) ratio at approximately 2.94 times as of November 13, 2025, which is still relatively low compared to historical levels [17]. Industry Important Data - **Pig Farming**: The average price of external three yuan pigs decreased from 12.52 CNY/kg to 11.74 CNY/kg during the reporting period. The cost of corn and soybean meal showed fluctuations, with corn priced at 2260.39 CNY/ton and soybean meal at 3072 CNY/ton as of November 13, 2025 [21][23]. - **Profitability**: As of November 14, 2025, self-breeding pig farming reported a loss of 114.81 CNY per head, while purchasing piglets resulted in a loss of 205.64 CNY per head, indicating a decline in profitability [26]. - **Poultry Farming**: The average price of broiler chicks was 3.49 CNY per chick, slightly down from the previous week, while the average price of white feather broilers increased to 7.12 CNY/kg, with a loss of 0.95 CNY per bird [28][31]. Industry Important News - The Ministry of Agriculture and Rural Affairs emphasized accelerating the self-reliance and controllability of seed technology during a recent meeting, highlighting the importance of domestic seed sources and innovation in the seed industry [35]. Company Important News - Key companies to watch include Muyuan Foods (002714), Wens Foodstuff Group (300498), and others, which are positioned to benefit from industry trends and potential recovery in profitability [48][49].

Core Viewpoint - The animal health sector experienced a slight increase of 0.89% on November 14, with *ST Green Kang leading the gains, while the overall market indices, including the Shanghai Composite Index and Shenzhen Component Index, saw declines of 0.97% and 1.93% respectively [1] Group 1: Market Performance - The closing price of *ST Green Kang was 40.54, reflecting a rise of 5.00% with a trading volume of 204,000 shares and a transaction value of 8.27 million yuan [1] - Other notable performers included Ruipu Biology with a closing price of 21.23, up 1.87%, and Biological Shares at 11.93, up 1.62% [1] - The overall trading volume and transaction values for various companies in the animal health sector were significant, with Biological Shares recording a transaction value of 954 million yuan [1] Group 2: Capital Flow - The animal health sector saw a net outflow of 57.68 million yuan from institutional investors, while retail investors contributed a net inflow of 60.01 million yuan [2] - The capital flow data indicates that *ST Green Kang had a net inflow of 1.42 million yuan from institutional investors, despite a net outflow from retail investors [3] - Other companies like Biological Shares and Ruipu Biology experienced significant net outflows from institutional investors, indicating a shift in investment sentiment [3]

Core Viewpoint - As of November 10, 2025, the total number of shareholders for Reap Bio (300119) is expected to exceed 25,000 [1] Company Summary - Reap Bio has communicated to investors that the total number of shareholders will be over 25,000 by the specified date [1]